Your browser doesn't support javascript.
loading
Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform.
Lauterbach, Henning; Schmidt, Sarah; Katchar, Kia; Qing, Xiaoping; Iacobucci, Corinne; Hwang, Andy; Schlienger, Katia; Berka, Ursula; Raguz, Josipa; Ahmadi-Erber, Sarah; Schippers, Timo; Stemeseder, Felix; Pinschewer, Daniel D; Matushansky, Igor; Orlinger, Klaus K.
Afiliação
  • Lauterbach H; Hookipa Pharma Inc., New York, NY, United States.
  • Schmidt S; Hookipa Pharma Inc., New York, NY, United States.
  • Katchar K; Hookipa Pharma Inc., New York, NY, United States.
  • Qing X; Hookipa Pharma Inc., New York, NY, United States.
  • Iacobucci C; Hookipa Pharma Inc., New York, NY, United States.
  • Hwang A; Hookipa Pharma Inc., New York, NY, United States.
  • Schlienger K; Hookipa Pharma Inc., New York, NY, United States.
  • Berka U; Hookipa Pharma Inc., New York, NY, United States.
  • Raguz J; Hookipa Pharma Inc., New York, NY, United States.
  • Ahmadi-Erber S; Hookipa Pharma Inc., New York, NY, United States.
  • Schippers T; Hookipa Pharma Inc., New York, NY, United States.
  • Stemeseder F; Hookipa Pharma Inc., New York, NY, United States.
  • Pinschewer DD; Department of Biomedicine - Haus Petersplatz, Division of Experimental Virology, University of Basel, Basel, Switzerland.
  • Matushansky I; Hookipa Pharma Inc., New York, NY, United States.
  • Orlinger KK; Hookipa Pharma Inc., New York, NY, United States.
Front Oncol ; 11: 732166, 2021.
Article em En | MEDLINE | ID: mdl-34722273

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article